|
1
|
Gerald D, Chintharlapalli S, Augustin HG
and Benjamin LE: Angiopoietin-2: an attractive target for improved
antiangiogenic tumor therapy. Cancer Res. 73:1649–1657. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Turley RS, Fontanella AN, Padussis JC, et
al: Bevacizumab-induced alterations in vascular permeability and
drug delivery: a novel approach to augment regional chemotherapy
for in-transit melanoma. Clin Cancer Res. 18:3328–3339. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peng F, Xu Z, Wang J, et al: Recombinant
human endostatin normalizes tumor vasculature and enhances
radiation response in xenografted human nasopharyngeal carcinoma
models. PLoS One. 7:e346462012. View Article : Google Scholar
|
|
4
|
Sagar SM, Yance D and Wong RK: Natural
health products that inhibit angiogenesis: a potential source for
investigational new agents to treat cancer - Part 2. Curr Oncol.
13:99–107. 2006.
|
|
5
|
Li SY, Ling LH, Teh BS, Seow WK and Thong
YH: Anti-inflammatory and immunosuppressive properties of the
bis-benzylisoquinolines: in vitro comparisons of tetrandrine and
berbamine. Int J Immunopharmacol. 11:395–401. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen Y, Chen JC and Tseng SH: Tetrandrine
suppresses tumor growth and angiogenesis of gliomas in rats. Int J
Cancer. 124:2260–2269. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lai JH: Immunomodulatory effects and
mechanisms of plant alkaloid tetrandrine in autoimmune diseases.
Acta Pharmacol Sin. 23:1093–1101. 2002.PubMed/NCBI
|
|
8
|
Wang G, Lemos JR and Iadecola C: Herbal
alkaloid tetrandrine: fron an ion channel blocker to inhibitor of
tumor proliferation. Trends Pharmacol Sci. 25:120–123. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu C, Gong K, Mao X and Li W: Tetrandrine
induces apoptosis by activating reactive oxygen species and
repressing Akt activity in human hepatocellular carcinoma. Int J
Cancer. 129:1519–1531. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JH, Kang GH, Kim KC, et al:
Tetrandrine-induced cell cycle arrest and apoptosis in A549 human
lung carcinoma cells. Int J Oncol. 21:1239–1244. 2002.PubMed/NCBI
|
|
11
|
Li X, Su B, Liu R, Wu D and He D:
Tetrandrine induces apoptosis and triggers caspase cascade in human
bladder cancer cells. J Surg Res. 166:e45–51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu JM, Chen Y, Chen JC, Lin TY and Tseng
SH: Tetrandrine induces apoptosis and growth suppression of colon
cancer cells in mice. Cancer Lett. 287:187–195. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gong K, Chen C, Zhan Y, Chen Y, Huang Z
and Li W: Autophagy-related gene 7 (ATG7) and reactive oxygen
species/extracellular signal-regulated kinase regulate
tetrandrine-induced autophagy in human hepatocellular carcinoma. J
Biol Chem. 287:35576–35588. 2012. View Article : Google Scholar
|
|
14
|
Yu J, Tian S, Metheny-Barlow L, et al:
Modulation of endothelial cell growth arrest and apoptosis by
vascular endothelial growth inhibitor. Circ Res. 89:1161–1167.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuo PL and Lin CC: Tetrandrine-induced
cell cycle arrest and apoptosis in Hep G2 cells. Life Sci.
73:243–252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kobayashi S, Inaba K, Kimura I and Kimura
M: Inhibitory effects of tetrandrine on angiogenesis in
adjuvant-induced chronic inflammation and tube formation of
vascular endothelial cells. Biol Pharm Bull. 21:346–349. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao JL, Ji X, He TC, et al: Tetrandrine
suppresses cancer angio-genesis and metastasis in 4T1 tumor bearing
mice. Evid Based Complement Alternat Med.
2013:2650612013.PubMed/NCBI
|
|
18
|
Felbor U, Dreier L, Bryant RA, Ploegh HL,
Olsen BR and Mothes W: Secreted cathepsin L generates endostatin
from collagen XVIII. EMBO J. 19:1187–1194. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wen W, Moses MA, Wiederschain D, Arbiser
JL and Folkman J: The generation of endostatin is mediated by
elastase. Cancer Res. 59:6052–6056. 1999.PubMed/NCBI
|
|
20
|
Gordillo GM, Onat D, Stockinger M, et al:
A key angiogenic role of monocyte chemoattractant protein-1 in
hemangioendothelioma proliferation. Am J Physiol Cell Physiol.
287:C866–C873. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Obeso J, Weber J and Auerbach R: A
hemangioendothelioma-derived cell line: its use as a model for the
study of endothelial cell biology. Lab Invest. 63:259–269.
1990.PubMed/NCBI
|
|
22
|
Lannutti BJ, Gately ST, Quevedo ME, Soff
GA and Paller AS: Human angiostatin inhibits murine
hemangioendothelioma tumor growth in vivo. Cancer Res.
57:5277–5280. 1997.PubMed/NCBI
|
|
23
|
O’Reilly MS, Brem H and Folkman J:
Treatment of murine hemangioendotheliomas with the angiogenesis
inhibitor AGM-1470. J Pediatr Surg. 30:325–330. 1995.PubMed/NCBI
|
|
24
|
O’Reilly MS, Boehm T, Shing Y, et al:
Endostatin: an endogenous inhibitor of angiogenesis and tumor
growth. Cell. 88:277–285. 1997.
|
|
25
|
Koukourakis MI, Giatromanolaki A, Thorpe
PE, et al: Vascular endothelial growth factor/KDR activated
microvessel density versus CD31 standard microvessel density in
non-small cell lung cancer. Cancer Res. 60:3088–3095.
2000.PubMed/NCBI
|
|
26
|
Qin L, Zhao D, Liu X, et al: Down syndrome
candidate region 1 isoform 1 mediates angiogenesis through the
calcineurin-NFAT pathway. Mol Cancer Res. 4:811–820. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Davani S, Marandin A, Mersin N, et al:
Mesenchymal progenitor cells differentiate into an endothelial
phenotype, enhance vascular density, and improve heart function in
a rat cellular cardiomyoplasty model. Circulation. 108(Suppl 1):
II253–II258. 2003. View Article : Google Scholar
|
|
28
|
Li X, Lu X, Xu H, et al:
Paclitaxel/tetrandrine coloaded nanoparticles effectively promote
the apoptosis of gastric cancer cells based on ‘oxidation therapy’.
Mol Pharm. 9:222–229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Heinzelmann S and Bauer G: Multiple
protective functions of catalase against intercellular
apoptosis-inducing ROS signaling of human tumor cells. Biol Chem.
391:675–693. 2010. View Article : Google Scholar
|
|
30
|
Fatehi-Hassanabad Z, Chan CB and Furman
BL: Reactive oxygen species and endothelial function in diabetes.
Eur J Pharmacol. 636:8–17. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ferreira AK, de-Sa-Junior PL, Pasqualoto
KF, et al: Cytotoxic effects of dillapiole on MDA-MB-231 cells
involve the induction of apoptosis through the mitochondrial
pathway by inducing an oxidative stress while altering the
cytoskeleton network. Biochimie. 99:195–207. 2013. View Article : Google Scholar
|
|
32
|
Gong K, Xie J, Yi H and Li W: CS055
(Chidamide/HBI-8000), a novel histone deacetylase inhibitor,
induces G1 arrest, ROS-dependent apoptosis and differentiation in
human leukaemia cells. Biochem J. 443:735–746. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sheppard K, Kinross KM, Solomon B, Pearson
RB and Phillips WA: Targeting PI3 kinase/AKT/mTOR signaling in
cancer. Crit Rev Oncog. 17:69–95. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Janku F, McConkey DJ, Hong DS and Kurzrock
R: Autophagy as a target for anticancer therapy. Nat Rev Clin
Oncol. 8:528–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Song MS, Salmena L and Pandolfi PP: The
functions and regulation of the PTEN tumour suppressor. Nat Rev Mol
Cell Biol. 13:283–296. 2012.PubMed/NCBI
|
|
36
|
Liu P, Begley M, Michowski W, et al:
Cell-cycle-regulated activation of Akt kinase by phosphorylation at
its carboxyl terminus. Nature. 508:541–545. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang Y, Wang C, Wang H, Wang K, Du Y and
Zhang J: Combination of Tetrandrine with cisplatin enhances
cytotoxicity through growth suppression and apoptosis in ovarian
cancer in vitro and in vivo. Cancer Lett. 304:21–32. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
McCubrey JA, Basecke J, Cervello M,
Martelli AM and Franklin RA: GSK-3beta is a critical mediator of
tetrandrine induced cell cycle arrest and cytotoxicity. Cancer Biol
Ther. 7:10792008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee HG, Lee YJ and Yang JH:
Perfluorooctane sulfonate induces apoptosis of cerebellar granule
cells via a ROS-dependent protein kinase C signaling pathway.
Neurotoxicology. 33:314–320. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lu CY, Yang YC, Li CC, Liu KL, Lii CK and
Chen HW: Andrographolide inhibits TNFalpha-induced ICAM-1
expression via suppression of NADPH oxidase activation and
induction of HO-1 and GCLM expression through the PI3K/Akt/Nrf2 and
PI3K/Akt/AP-1 pathways in human endothelial cells. Biochem
Pharmacol. 91:40–50. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Muniz-Feliciano L, Van Grol J, Portillo
JA, et al: Toxoplasma gondii-induced activation of EGFR prevents
autophagy protein-mediated killing of the parasite. PLoS Pathog.
9:e10038092013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rodon J, Dienstmann R, Serra V and
Tabernero J: Development of PI3K inhibitors: lessons learned from
early clinical trials. Nat Rev Clin Oncol. 10:143–153. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qin L, Zeng H and Zhao D: Requirement of
protein kinase D tyrosine phosphorylation for VEGF-A165-induced
angiogenesis through its interaction and regulation of
phospholipase Cgamma phosphorylation. J Biol Chem. 281:32550–32558.
2006. View Article : Google Scholar : PubMed/NCBI
|
